IP Library Granted Patent US 9,089,487
Granted Patent B2
US 9,089,487 · App. 13/870,556 · Granted Jul 28, 2015

Crystalline microspheres and the process of manufacturing the same

Inventors: Cecil W. Propst (Norton Shores, MI); Marc W. Meadows (Grand Haven, MI); Michael S. Todd (Grand Haven, MI)
Assignee: SPI Pharma, Inc.
A61K9/16A61K9/1623
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,089,487
App. No.
13/870,556
Granted
Jul 28, 2015
Kind
B2
Abstract

The present invention relates to microspheres comprising a core material, wherein the microsphere is perfectly spherical and has a moisture content less than 1%, and the method of manufacturing the same. The present invention is useful in the manufacture of sustained and modified release active pharmaceutical ingredient (API) microspheres, as a free flowing excipient for mini-tablets and in the manufacture of API dispersions.

Claims (24)

1. A microsphere comprising a core material, wherein the microsphere has a circularity greater than 0.95, an aspect ratio greater than 0.95, and lacks porosity.

2. The microsphere of claim 1 , wherein the microsphere has a mean particle size from about 10 μm to about 500 μm.

3. The microsphere of claim 2 , wherein the microsphere has a mean particle size from about 10 μm to about 20 μm.

4. The microsphere of claim 3 , wherein the microsphere has a moisture content of 0.5% or less.

5. The microsphere of claim 1 , wherein the microsphere has a particle size distribution of 2.8 or less.

6. The microsphere of claim 5 , wherein the microsphere has a particle size distribution of 2.0 or less.

7. The microsphere of claim 5 , wherein the microsphere has a particle size distribution of 1.5 or less.

8. The microsphere of claim 5 , wherein the microsphere has a particle size distribution of 1.0.

9. The microsphere of claim 1 , wherein the microsphere has a surface with ridges of 10 μm or less.

10. The microsphere of claim 1 , wherein the microsphere has a skeletal density from about 1.4595 g/cc to about 1.4651 g/cc.

11. The microsphere of claim 1 , wherein the microsphere has a moisture content of 0.5% or less.

12. The microsphere of claim 11 , wherein the microsphere has a moisture content of 0.1% or less.

13. The microsphere of claim 11 , wherein the microsphere has a moisture content of 0.0%.

14. The microsphere of claim 1 , wherein the microsphere is water soluble.

15. The microsphere of claim 1 , wherein the microsphere comprises a single core material.

16. The microsphere of claim 15 , wherein the single core material is mannitol.

17. The microsphere of claim 1 , wherein the microsphere comprises a 100% crystalline core.

18. The microsphere of claim 1 , wherein the microsphere further comprises an active pharmaceutical ingredient.

19. The microsphere of claim 1 , wherein the core material is a polyol.

20. The microsphere of claim 19 , wherein the polyol is mannitol.

21. The microsphere of claim 1 , wherein the microsphere lacks internal voids.

22. A composition comprising the microsphere of claim 1 .

23. The composition of claim 22 further comprising an active pharmaceutical ingredient.

24. A microsphere comprising a core material, wherein the microsphere has a circularity greater than 0.95, an aspect ratio greater than 0.95, and a moisture content of 0.5% or less.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 15, 2014
From: PROPST, CECIL; MEADOWS, MARC W.; TODD, MICHAEL S.
To: SPI PHARMA, INC.
Reel/Frame 033955/0967 →
Continuity (3)
Provisional Application 61638073 · Apr 25, 2012
Provisional Application 61783603 · Mar 14, 2013
Related Publication 20140099372A1 · Apr 10, 2014